Overview

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain.

Status:
Recruiting

Trial end date:
2020-06-10

Target enrollment:

Participant gender:

Summary

This study was to evaluate the efficacy and safety of intravenously administered ibuprofen 400mg and 800 mg q6h for the management of moderate to severe postoperative pain in Chinese population.

Phase:

Phase 3

Details

Lead Sponsor:

Yi Feng, MD

Treatments:

Ibuprofen